The Effects of Caffeine and L-theanine Both Alone and in Combination on Cerebral Blood Flow, Cognition and Mood

Phase 4

Completed

• Conditions: Cognitive Function; Mood
• Interventions: Dietary Supplement: Caffeine and L-theanine

• Registration Number: NCT00981955
• Lead Sponsor: Northumbria University

Brief Summary

Although the beneficial effects of caffeine on cognition and mood have been reported in a number of studies, relatively few studies have looked at the effects of caffeine in combination with other phytonutrients despite the fact that caffeine is seldom consumed in isolation. L-theanine is a naturally occurring amino-acid found in tea, and has been used historically as a relaxing agent (Haskell et al., 2008). Few have assessed the impact of l-theanine on cognition, but of those that have, the most interesting results were obtained when l-theanine was assessed in combination with caffeine (Haskell et al., 2008). It remains unclear what is underlying the reported effects.

Near Infrared Spectroscopy (NIRS) is an emerging neuroimaging technology that is capable of determining changes in cerebral blood flow (CBF) by measuring the optical properties of oxygenated and deoxygenated blood (Bunce et al., 2006). No study to date has used NIRS to assess cerebral blood flow following treatment with either caffeine, l-theanine or a combination of both. It is anticipated that the proposed study will provide some insight into the mechanism of the previously observed effects both alone and in combination.

A randomised, double-blind, placebo controlled, balanced crossover design study will assess the effects of 75mg caffeine, 50mg l-theanine and a 75mg caffeine/50mg l-theanine combination in 24 young healthy adults (18-35). Cognitive and mood assessments will take place at baseline and at 30 minutes following treatment whilst cerebral haemodynamics are measured via the technique of NIRS.

Detailed Description

Not available

Study Timeline

• Study Start: 2009-08
• Study First Submitted: 2009-09-21
• Study First Submitted QC: 2009-09-21
• Study First Posted: 2009-09-22
• Primary Completion: 2010-02
• Study Completion: 2010-02
• Status Verified: 2010-07
• Last Update Submitted: 2010-07-22
• Last Update Posted: 2010-07-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• Healthy
• Aged 18-35
• Either caffeine consumers (consume more than 150mg caffeine per day) or non-consumers (less than 44mg caffeine per day).

Exclusion Criteria

• Smoke or consume any tobacco products
• Not proficient in English language
• Pregnant (or seeking to become pregnant)
• Taking recreational, over the counter/prescription medication (including the contraceptive pill), and/or dietary/herbal supplements
• Have food allergies or sensitivities
• Have history of/current head trauma, learning difficulties , ADHD, migraines or any gastric problems

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
75mg caffeine	Caffeine and L-theanine	-
50mg l-theanine	Caffeine and L-theanine	-
75mg caffeine and 50mg l-theanine	Caffeine and L-theanine	-
0mg caffeine/l-theanine	Caffeine and L-theanine	-

Primary Outcome Measures

Name	Time	Method
Cerebral blood flow	0-80 minutes post dose
Cognitive function	0-70 minutes post-dose
Mood	85 minutes post dose

Trial Locations

Locations (1)

Northumbria University; 🇬🇧 Newcastle upon Tyne, Tyne & Wear, United Kingdom